Publications by authors named "P Cassier"

Claim this Profile
P
Phase Ib and dose-expansion study of GSK3326595, a PRMT5 inhibitor as monotherapy and in combination with pembrolizumab in patients with advanced cancers.
M M Gounder, P Martin-Romano, A Italiano, L L Siu, P A Cassier

Ann Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbapenemase-producing Enterobacterales in the hospital water environment: a narrative review.
Léna Sleiman, Christelle Elias, Pierre Cassier, Marisa Haenni, Jean-Yves Madec

Clin Microbiol Infect· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Olomorasib in Combination With Pembrolizumab in Treatment of Patients With KRAS G12C-Mutant Advanced NSCLC.
Timothy F Burns, Natraj Reddy Ammakkanavar, Antoine Hollebecque, Dae Ho Lee, Takafumi Koyama, Philippe A Cassier

J Thorac Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD40 agonist mitazalimab with mFOLFIRINOX in untreated metastatic pancreatic cancer: Biomarkers associated with outcomes from OPTIMIZE-1.
Jean-Luc Van Laethem, Karen Geboes, Ivan Borbath, Teresa Macarulla Mercade, Aurélien Lambert, Philippe Cassier

Cell Rep Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Understanding Serratia bockelmannii transmission during a neonatal intensive care unit outbreak: a combined genotyping and case-control study.
Kaisa Jaakkola, Aurélie Fischer, Louise Piquart, Pierre Cassier, Olivier Dauwalder

Antimicrob Resist Infect Control· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis